Clinicopathological Risk Factors for Contralateral Lymph Node Metastases in Intraoral Squamous Cell Carcinoma: A Study of 331 Cases.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
14 05 2021
Historique:
received: 12 04 2021
revised: 23 04 2021
accepted: 08 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 25 9 2021
Statut: epublish

Résumé

The current study aimed to examine the effects of clinicopathological factors, including the region, midline involvement, T classification, histological grade, and differentiation of the tumor on the rate of contralateral lymph node metastasis for oral squamous cell carcinoma and to assess their effects on survival rates. A total of 331 patients with intraoral squamous cell carcinomas were included. The influence of tumor location, T status, midline involvement, tumor grading, and the infiltration depth of the tumor on the pattern of metastasis was evaluated. Additionally, the effect of contralateral metastases on the prognosis was examined. Metastases of the contralateral side occurred most frequently in squamous cell carcinomas of the palate and floor of the mouth. Furthermore, tumors with a high T status resulted in significantly higher rates of contralateral metastases. Similarly, the midline involvement, tumor grading, existing ipsilateral metastases, and the infiltration depth of the tumor had a highly significant influence on the development of lymph node metastases on the opposite side. Oral squamous cell carcinomas require a patient-specific decision. There is an ongoing need for further prospective studies to confirm the validity of the prognostic factors described herein.

Identifiants

pubmed: 34069011
pii: curroncol28030175
doi: 10.3390/curroncol28030175
pmc: PMC8161834
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1886-1898

Références

Head Neck. 1999 Mar;21(2):104-10
pubmed: 10091977
Oral Oncol. 1997 Sep;33(5):302-12
pubmed: 9415327
Laryngoscope. 2009 May;119(5):883-8
pubmed: 19180635
Laryngorhinootologie. 2001 Jan;80(1):27-35
pubmed: 11272244
Cancer. 2009 Apr 1;115(7):1489-97
pubmed: 19197973
Braz J Otorhinolaryngol. 2012 Dec;78(6):15-20
pubmed: 23306562
Oral Oncol. 1999 May;35(3):257-65
pubmed: 10621845
J Oral Maxillofac Surg. 2010 Feb;68(2):268-75
pubmed: 20116694
Ann Med Surg (Lond). 2020 Nov 10;60:403-407
pubmed: 33235716
J Oral Maxillofac Surg. 2021 Feb 24;:
pubmed: 33744243
Oral Oncol. 2008 Dec;44(12):1134-8
pubmed: 18486527
PLoS One. 2013;8(1):e53415
pubmed: 23349710
Oral Oncol. 2004 Sep;40(8):780-6
pubmed: 15288831
J Clin Oncol. 2001 Nov 1;19(21):4107-16
pubmed: 11689578
CA Cancer J Clin. 1995 Nov-Dec;45(6):328-51
pubmed: 7583906
Br J Oral Maxillofac Surg. 1999 Jun;37(3):175-80
pubmed: 10454023
Int J Oral Sci. 2011 Oct;3(4):180-91
pubmed: 22010576
Mund Kiefer Gesichtschir. 2000 May;4 Suppl 1:S216-25
pubmed: 10938662
Arch Otolaryngol Head Neck Surg. 1991 Jun;117(6):601-5
pubmed: 2036180
Head Neck. 1998 Mar;20(2):138-44
pubmed: 9484945
Oral Oncol. 2004 Oct;40(9):898-903
pubmed: 15380167
Head Neck. 2006 Oct;28(10):896-901
pubmed: 16721743
Br J Oral Maxillofac Surg. 2005 Aug;43(4):281-4
pubmed: 15993279
Am J Surg. 1996 Dec;172(6):650-3
pubmed: 8988669
Laryngoscope. 2006 Mar;116(3):461-5
pubmed: 16540910
Head Neck. 2011 Feb;33(2):239-43
pubmed: 20848445
Cureus. 2020 Nov 23;12(11):e11640
pubmed: 33376652
N Engl J Med. 2015 Aug 6;373(6):521-9
pubmed: 26027881
Br J Oral Maxillofac Surg. 2019 Dec;57(10):1092-1097
pubmed: 31677799

Auteurs

Christian Flörke (C)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Aydin Gülses (A)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Christina-Randi Altmann (CR)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Jörg Wiltfang (J)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Henning Wieker (H)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Hendrik Naujokat (H)

Department of Oral and Maxillofacial Surgery, Christian Albrechts University, UKSH, 24105 Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH